1-161223893-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The variant allele was found at a frequency of 0.68 in 151,986 control chromosomes in the GnomAD database, including 35,682 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.68 ( 35682 hom., cov: 30)

Consequence

Unknown

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter P:1U:1

Conservation

PhyloP100: 0.00100

Publications

147 publications found
Variant links:

Genome browser will be placed here

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.887 is higher than 0.05.

Variant Effect in Transcripts

 

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

Frequencies

GnomAD3 genomes
AF:
0.679
AC:
103182
AN:
151868
Hom.:
35628
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.769
Gnomad AMI
AF:
0.584
Gnomad AMR
AF:
0.710
Gnomad ASJ
AF:
0.618
Gnomad EAS
AF:
0.909
Gnomad SAS
AF:
0.749
Gnomad FIN
AF:
0.621
Gnomad MID
AF:
0.623
Gnomad NFE
AF:
0.610
Gnomad OTH
AF:
0.665
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.680
AC:
103295
AN:
151986
Hom.:
35682
Cov.:
30
AF XY:
0.683
AC XY:
50708
AN XY:
74288
show subpopulations
African (AFR)
AF:
0.769
AC:
31853
AN:
41436
American (AMR)
AF:
0.711
AC:
10856
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.618
AC:
2146
AN:
3472
East Asian (EAS)
AF:
0.908
AC:
4698
AN:
5172
South Asian (SAS)
AF:
0.749
AC:
3607
AN:
4818
European-Finnish (FIN)
AF:
0.621
AC:
6555
AN:
10564
Middle Eastern (MID)
AF:
0.633
AC:
186
AN:
294
European-Non Finnish (NFE)
AF:
0.610
AC:
41451
AN:
67940
Other (OTH)
AF:
0.668
AC:
1413
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1623
3246
4870
6493
8116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
806
1612
2418
3224
4030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.637
Hom.:
120136
Bravo
AF:
0.694
Asia WGS
AF:
0.836
AC:
2900
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hypercholesterolemia, familial, 1 Pathogenic:1
Jan 01, 2002
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

Apolipoprotein A-II amyloidosis Uncertain:1
Apr 17, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
3.4
DANN
Benign
0.36
PhyloP100
0.0010
PromoterAI
-0.0068
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5082; hg19: chr1-161193683; API